Procter & Gamble Stock Forecast for 2023 - 2025 - 2030

Updated on 02/01/2023

Stock Rating
12
Price Target
$155.50
Consensus
Outperform
Upside
9.21%
Analysts
12
Stock Rating
12
Upside
9.21%
Analysts
12
Price Target
$155.50

Procter & Gamble Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Procter & Gamble were recently set by twelve distinguished experts, with an average mark of $155.50. If it reached this goal, it would represent a potential upside of approximately 9.21% from the previous closing price in January, 2023. The high end is $170.00, and the low is $126.00. If you are interested in PG stock, you should also look at its competitors.

$155.50

9.21% Upside

Outperform
Outperform

Procter & Gamble Fair Value Forecast for 2023 - 2025 - 2030

Procter & Gamble's Price has grown In the last three years, rising from $107.21 to $142.32 – a growth of 32.74%. In the next year, analysts believe that Fair Value will reach $148.49 – an increase of 4.33%. For the next eight years, experts predict that Procter & Gamble's Fair Value will grow at a rate of 56.17%.

2023 Fair Value Forecast
$148.49
2024 Fair Value Forecast
$161.53
2025 Fair Value Forecast
$175.53
2026 Fair Value Forecast
$197.11
2027 Fair Value Forecast
$185.96
2028 Fair Value Forecast
$197.82
2029 Fair Value Forecast
$208.97
2030 Fair Value Forecast
$222.26
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 11
$163.42 Buy/Sell $181.05 10.45%
ABBV Stock Forecast AbbVie Outperform 10
$147.74 Buy/Sell $162.12 11.68%
COST Stock Forecast Costco Wholesale Corp Outperform 13
$511.23 Buy/Sell $550.07 7.09%
ABT Stock Forecast Abbott Laboratories Outperform 10
$110.55 Buy/Sell $116.63 13.07%
MO Stock Forecast Altria Group Hold 4
$45.03 Buy/Sell $49.25 9.93%

Procter & Gamble Revenue Forecast for 2023 - 2025 - 2030

Procter & Gamble's Revenue has grown In the last three years, rising from $67.68B to $80187.00T – a growth of 118472508.00%. According to the 20 analysts polled, in the next year, Procter & Gamble's Revenue will fall by 100.00%, reaching $82.95B. By 2030, professionals believe that Procter & Gamble's Revenue will have decreased by 100.00%, falling to $106.73B.

2023 Rev Forecast
$82.95B
2024 Rev Forecast
$86.53B
2025 Rev Forecast
$90.10B
2026 Rev Forecast
$95.82B
2027 Rev Forecast
$95.49B
2028 Rev Forecast
$99.14B
2029 Rev Forecast
$102.80B
2030 Rev Forecast
$106.73B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GSK Stock Forecast GSK Hold 16
£1.42k Buy/Sell £16.95 -98.87%
KER Stock Forecast Kering Outperform 18
527.60€ Buy/Sell 621.06€ 17.51%
CL Stock Forecast Colgate-Palmolive Co Outperform 18
$74.53 Buy/Sell $81.35 10.02%

Procter & Gamble Dividend per Share Forecast for 2023 - 2025 - 2030

Procter & Gamble's Dividend per Share has seen impressive growth In the last three years, rising from $2.90 to $3.65 – a growth of 25.86%. In the next year, analysts believe that Dividend per Share will reach $3.71 – an increase of 1.64%. For the next eight years, the forecast is for Dividend per Share to grow by 61.64%.

2023 DPS Forecast
$3.71
2024 DPS Forecast
$3.88
2025 DPS Forecast
$4.14
2026 DPS Forecast
$4.64
2027 DPS Forecast
$4.75
2028 DPS Forecast
$5.10
2029 DPS Forecast
$5.49
2030 DPS Forecast
$5.90
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAYN Stock Forecast Bayer Outperform 7
57.00€ Buy/Sell 74.54€ 32.46%
GIS Stock Forecast General Mills Hold 16
$78.36 Buy/Sell $81.79 4.65%
ALC Stock Forecast Alcon Outperform 15
CHF66.18 Buy/Sell CHF0.00 30.51%

Procter & Gamble Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, Procter & Gamble's Free Cash Flow has grown, moving from $11.90B to $16808.00T – an increase of 141302941.98%. In the following year, 8 experts forecast Procter & Gamble's Free Cash Flow will decrease by 100.00%, to $15.74B. In 2030, professionals predict that Procter & Gamble's Free Cash Flow will decrease by 100.00%, to $21.42B.

2023 FCF Forecast
$15.74B
2024 FCF Forecast
$16.89B
2025 FCF Forecast
$17.82B
2026 FCF Forecast
$18.94B
2027 FCF Forecast
$18.94B
2028 FCF Forecast
$19.79B
2029 FCF Forecast
$20.51B
2030 FCF Forecast
$21.42B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BN Stock Forecast Danone Hold 18
49.65€ Buy/Sell 55.47€ 11.78%
HEN3 Stock Forecast Henkel AG & Co. KGaA Hold 16
65.40€ Buy/Sell 66.02€ 1.68%
COLO B Stock Forecast Coloplast A/S Hold 18
kr848.20 Buy/Sell kr1.05k 21.43%

Procter & Gamble Net Income Forecast for 2023 - 2025 - 2030

In the last three years, Procter & Gamble's Net Income has grown by 379599592.07%, rising from $3.90B to $14793.00T. According to 18 prominent analysts, Procter & Gamble's Net Income will fall by 100.00% in the next year, reaching $15.66B. By 2030, professionals believe that Procter & Gamble's Net Income will decrease by 100.00%, reaching $20.82B – a concerning trend for the company.

2023 NI Forecast
$15.66B
2024 NI Forecast
$16.73B
2025 NI Forecast
$17.56B
2026 NI Forecast
$19.07B
2027 NI Forecast
$18.37B
2028 NI Forecast
$19.20B
2029 NI Forecast
$19.92B
2030 NI Forecast
$20.82B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
K Stock Forecast Kellogg Hold 13
$68.58 Buy/Sell $73.45 7.90%
4452 Stock Forecast Kao Outperform 18
¥5.11k Buy/Sell ¥0.00 17.53%
CHD Stock Forecast Church & Dwight Co Inc Hold 11
$80.87 Buy/Sell $82.17 5.11%

Procter & Gamble EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Procter & Gamble's EBITDA has seen an increase, rising from $16.66B to $21241.00T. This represents a growth of 127527517.68%. According to 18 major analysts, Procter & Gamble's EBITDA will fall by 100.00% in the next year, reaching $22.25B. Professionals believe that By 2030, Procter & Gamble's EBITDA will fall to $29.99B– a 100.00% decrease from its current value.

2023 EBITDA Forecast
$22.25B
2024 EBITDA Forecast
$23.74B
2025 EBITDA Forecast
$25.53B
2026 EBITDA Forecast
$27.03B
2027 EBITDA Forecast
$26.55B
2028 EBITDA Forecast
$27.71B
2029 EBITDA Forecast
$28.73B
2030 EBITDA Forecast
$29.99B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CPB Stock Forecast Campbell Soup Hold 16
$57.01 Buy/Sell $52.53 -7.03%
PHIA Stock Forecast Koninklijke Philips N.V. Outperform 18
15.33€ Buy/Sell 50.07€ 98.96%
CA Stock Forecast Carrefour Outperform 18
16.02€ Buy/Sell 19.86€ 20.47%

Procter & Gamble EBIT Forecast for 2023 - 2025 - 2030

Procter & Gamble's EBIT has seen growth In the last three years, going from $13.83B to $17.81B – a gain of 28.78% In the next year, analysts believe that EBIT will reach $19.19B – an increase of 7.72%. For the next eight years, the forecast is forEBIT to grow by 47.53%.

2023 EBIT Forecast
$19.19B
2024 EBIT Forecast
$20.50B
2025 EBIT Forecast
$21.65B
2026 EBIT Forecast
$23.73B
2027 EBIT Forecast
$23.20B
2028 EBIT Forecast
$24.25B
2029 EBIT Forecast
$25.15B
2030 EBIT Forecast
$26.28B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BIM Stock Forecast bioMérieux Outperform 18
96.70€ Buy/Sell 105.55€ 11.17%
BBWI Stock Forecast Bath & Body Works Outperform 15
$46.01 Buy/Sell $51.40 6.50%
500124 Stock Forecast Dr. Reddy's Laboratories Outperform 18
Rp4.27k Buy/Sell Rp5.47k 15.97%

Procter & Gamble EPS Price Prediction Forecast for 2023 - 2025 - 2030

Procter & Gamble's EPS has grown In the last three years, rising from $4.52 to $6.00 – a growth of 32.74%. In the next year, analysts believe that EPS will reach $6.26 – an increase of 4.33%. For the next eight years, experts predict that Procter & Gamble's EPS will grow at a rate of 56.17%.

2023 EPS Forecast
$6.26
2024 EPS Forecast
$6.81
2025 EPS Forecast
$7.40
2026 EPS Forecast
$8.31
2027 EPS Forecast
$7.84
2028 EPS Forecast
$8.34
2029 EPS Forecast
$8.81
2030 EPS Forecast
$9.37
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
A090430 Stock Forecast Amorepacific Outperform 18
₩137.50k Buy/Sell ₩269.69k 52.36%
KIMBER A Stock Forecast Kimberly-Clark de México, S. ... Outperform 18
Mex$35.30 Buy/Sell Mex$40.00 -0.85%
HYPE3 Stock Forecast Hypera Outperform 16
R$46.69 Buy/Sell R$44.01 -6.83%